Where does MiRus LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), MiRus LLC ranks #6,467 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does MiRus LLC hold?

MiRus LLC holds 52 US utility patents granted between 2017 and 2025, spanning 22 technology areas.

What is MiRus LLC's Innovation Score?

MiRus LLC has an Innovation Score of 58.3 out of 100 (top 5% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is MiRus LLC's patent grant rate increasing or decreasing?

MiRus LLC's recent grant velocity is +925% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for MiRus LLC's patents?

MiRus LLC's patents average 13.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the MiRus LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

MiRus LLC

Q: What technology areas does MiRus LLC focus on?

MiRus LLC's top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 19 patents, ranking #347 of 3,082 assignees active in that subclass. Grants appear in 22 CPC subclasses total.

USPTO PatentsView assignee record - 52 granted patents across 22 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Mirus ranks #6,467 of 49,997 tracked US assignees by granted-patent volume, with 52 patents across 22 technology areas.

#6,467
of 49,997 US assignees by volume: Top 5%
by Innovation Score (58.3/100): 13.3
avg claims per patent: +925%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6467 · US Corporation #6,467 · 52 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 52 grants
UPPER-Q #6,467/49,997
PHOTO-FINISH Manitowoc Crane…
CPC-FOCUS A61F · 22 areas
INNOV-PAR 58.3/100
CLAIMS-RICH 13.3 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +925% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Manitowoc Crane Group France (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Mirus’s 58.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.7 pts (23%) Velocity 20.0 pts (34%) Breadth 16.6 pts (28%) Claim depth 8.0 pts (14%)

Qualcomm Incorporated · highest

85
Yissum Research… · near

58
Kerr Machine · near

58
MD Elektronik · near

58
MiRus · this assignee

58
Sensel · near

58
3D Lighting… · lowest

7

What this shows Mirus's Innovation Score is 58.3/100 (top 5% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Mirus?

Each dot is one of Mirus’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Mirus’s own 13.3 claims/patent is at or below the 14.9 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Mirus vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Mirus's grants concentrate

MiRus LLC is a focused PatentsView assignee: 22 CPC subclasses with 36.5% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2022 (15 grants) versus a trough of 1 in 2018. By volume, Mirus sits between Manitowoc Crane Group France and Nihon Nohyaku Co., Ltd..

Mirus's three-year grant acceleration

MiRus LLC shows 34 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Manitowoc Crane G…

52
Medivation

52
Medtronic Bakken…

52
Mettler-toledo (C…

52
Midmark

52
Monticello Enterp…

52
Multi-chem Group

52
Nihon Nohyaku

52
Mirus ◀

52

What this shows MiRus holds 52 patents at rank #6,467, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near MiRus

By rank, the assignees closest to #6,467 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in MiRus's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for MiRus, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), MiRus ranks #347 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (58 here).

MD Elektronik GMBH 58 Sensel, Inc. 58 Kerr Machine Co. 58 Yissum Research Development Company OF THE Hebrew University OF Jerusalem Ltd. 58

Similar claim depth

Nearest assignees by average claims per patent (13.3 here).

Valmet AB 13.3 avg Universite DE Rennes 13.3 avg Dalian Institute OF Chemical Physics, Chinese Academy OF Sciences 13.3 avg Specialized Bicycle Components, Inc. 13.3 avg

Mirus's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

58 Top 5% higher than 95% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

MiRus LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	2	3.8%
2018	1	1.9%
2019	1	1.9%
2020	5	9.6%
2021	2	3.8%
2022	15	28.8%
2023	6	11.5%
2024	13	25.0%
2025partial year	7	13.5%

Which technologies does MiRus LLC patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 19

A61B - DIAGNOSIS; SURGERY; Identification 17

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 7

C22C - Alloys 7

C22F - Changing THE Physical Structure OF Non-ferrous Metals AND Non-ferrous Alloys 5

B21C - Manufacture OF Metal Sheets, Wire, Rods, Tubes, Profiles OR Like Semi-manufactured Products Otherwise Than BY ROLLING; Auxiliary Operations Used IN Connection With Metal-working Without Essentially Removing Material 4

Y10S - Technical Subjects Covered BY Former Uspc Cross-reference ART Collections [XRACs] AND Digests 3

B06B - Methods OR Apparatus FOR Generating OR Transmitting Mechanical Vibrations OF Infrasonic, Sonic, OR Ultrasonic Frequency, ; e.g.; FOR Performing Mechanical Work IN General 2

A61C - DENTISTRY; Apparatus OR Methods FOR Oral OR Dental Hygiene 2

G02B - Optical Elements, Systems OR Apparatus 2

G06F - Electric Digital Data Processing 2

G09G - Arrangements OR Circuits FOR Control OF Indicating Devices Using Static Means TO Present Variable Information 2

G06T - Image Data Processing OR Generation, IN General 2

C23C - Coating Metallic MATERIAL; Coating Material With Metallic MATERIAL; Surface Treatment OF Metallic Material BY Diffusion Into THE Surface, BY Chemical Conversion OR SUBSTITUTION; Coating BY Vacuum Evaporation, BY Sputtering, BY ION Implantation OR BY Chemical Vapour Deposition, IN General 2

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 2

Top 15 of 22 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

MiRus LLC's patent record in context - here's where to go next.

MiRus LLC's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 36.5% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #6,467 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare MiRus LLC against Manitowoc Crane Group France, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 58.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.